Biology Needs a National Strategy

Amy Webb, Wired, 11 May 2017,

With the fast pace of CRISPR technology, the regulations and laws governing biology research cannot keep up.  This has become apparent with CRISPR genome editing. Despite the potential applications in research, medicine, and agriculture, control over how CRISPR technology is applied is determined by patent control.  In this opinion piece Amy Webb proposes that the United States needs a non-partisan panel of scientists, technologies, ethicists, policy experts, and futurists to develop strategic plans for biology.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply